New facilities offer innovative equipment and increased capacity to bring highly potent oncology therapies to market PHILADELPHIA – July 27, 2022 – PCI Pharma Services …

Analyses provided by UK cancer charity Macmillan has provided insights into the repercussions experienced by patients waiting to receive treatment during the COVID-19 pandemic. An …

Nykode Therapeutics, a clinical-stage biopharmaceutical company, announced that it has entered into a collaboration agreement with Regeneron. This partnership will focus on the discovery, development …

Cervical cancer if not caught early in the precancerous stage can be deadly. Approximately 250,000 women die each year around the world due to the …

Oxford Cancer Biomarkers Limited  has announced the launch of ToxNav – a genomic test to identify cancer patients at high risk of severe and potentially …

Aarhus University’s Interdisciplinary Nanoscience Center (iNANO) and Albumedix Ltd. (‘Albumedix’) have entered into a strategic research collaboration to evaluate the transport properties of albumin for …

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announce that Unicancer, a hospital group entirely devoted to fighting cancer, has selected …

European regulatory advisors are supporting approval of AstraZeneca’s lung cancer drug Tagrisso in the first-line setting. The Committee for Medicinal Products for Human Use (CHMP) …

Prime Minister Theresa May has announced an investment of £75 million into research targeting earlier diagnosis and better treatment for men with prostate cancer. The …

Phillips-Medisize, a Molex company, announces the expansion of a significant medical customer for the Molex Little Rock facility. The long-time customer is a leader in …